PL3331568T3 - Kompozycje stałego roztworu dla nlpz - Google Patents

Kompozycje stałego roztworu dla nlpz

Info

Publication number
PL3331568T3
PL3331568T3 PL16756963T PL16756963T PL3331568T3 PL 3331568 T3 PL3331568 T3 PL 3331568T3 PL 16756963 T PL16756963 T PL 16756963T PL 16756963 T PL16756963 T PL 16756963T PL 3331568 T3 PL3331568 T3 PL 3331568T3
Authority
PL
Poland
Prior art keywords
nsaids
solid solution
solution compositions
compositions
solid
Prior art date
Application number
PL16756963T
Other languages
English (en)
Inventor
Robin Mark Bannister
John Brew
Richard Robert REILEY
Wilson Caparros-Wanderley
Original Assignee
Infirst Healthcare Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/821,687 external-priority patent/US9744132B2/en
Priority claimed from EP15180256.8A external-priority patent/EP3127556A1/en
Application filed by Infirst Healthcare Limited filed Critical Infirst Healthcare Limited
Publication of PL3331568T3 publication Critical patent/PL3331568T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL16756963T 2015-08-07 2016-08-08 Kompozycje stałego roztworu dla nlpz PL3331568T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14/821,687 US9744132B2 (en) 2010-10-29 2015-08-07 Solid solution compositions and use in chronic inflammation
EP15180256.8A EP3127556A1 (en) 2015-08-07 2015-08-07 Solid solution compositions for nsaid
EP16756963.1A EP3331568B1 (en) 2015-08-07 2016-08-08 Solid solution compositions for nsaids
PCT/EP2016/068900 WO2017025517A1 (en) 2015-08-07 2016-08-08 SOLID SOLUTION COMPOSITIONS FOR NSAIDs

Publications (1)

Publication Number Publication Date
PL3331568T3 true PL3331568T3 (pl) 2022-02-28

Family

ID=56800263

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16756963T PL3331568T3 (pl) 2015-08-07 2016-08-08 Kompozycje stałego roztworu dla nlpz

Country Status (10)

Country Link
EP (2) EP3988091A1 (pl)
JP (1) JP6989489B2 (pl)
CN (1) CN108025078A (pl)
AU (1) AU2016306610B2 (pl)
CA (1) CA2994899C (pl)
ES (1) ES2906571T3 (pl)
IL (1) IL257385A (pl)
MX (1) MX2018001584A (pl)
PL (1) PL3331568T3 (pl)
WO (1) WO2017025517A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US8895537B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating cardiovascular diseases
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US9308213B2 (en) * 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US10695432B2 (en) * 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
ES2763352T3 (es) * 2013-01-14 2020-05-28 Infirst Healthcare Ltd Composiciones de solución sólida y uso en inflamación crónica

Also Published As

Publication number Publication date
ES2906571T3 (es) 2022-04-19
CA2994899A1 (en) 2017-02-16
AU2016306610A1 (en) 2018-03-01
CA2994899C (en) 2024-04-16
JP2018526351A (ja) 2018-09-13
WO2017025517A1 (en) 2017-02-16
MX2018001584A (es) 2019-01-31
EP3331568A1 (en) 2018-06-13
CN108025078A (zh) 2018-05-11
AU2016306610B2 (en) 2019-02-28
EP3331568B1 (en) 2021-12-15
IL257385A (en) 2018-04-30
JP6989489B2 (ja) 2022-01-05
EP3988091A1 (en) 2022-04-27

Similar Documents

Publication Publication Date Title
SG11201705415YA (en) Multi-supplement compositions
IL257131A (en) Preparations
IL257385A (en) Preparations containing non-steroidal anti-inflammatory substances
HK1251559A1 (zh) 普那布林組合物
GB201501598D0 (en) Compositions
HK1257500A1 (zh) 包含尿石素化合物的組合物
GB201505527D0 (en) Composition
GB201506827D0 (en) Composition
SG11201709762XA (en) Composition
GB201515391D0 (en) Compositions
GB201506829D0 (en) Composition
GB201506825D0 (en) Composition
GB201506830D0 (en) Composition
ZA201701169B (en) Anti-corrosion composition
SI3349766T1 (sl) Antihemoragični sestavki
GB201506828D0 (en) Composition
GB201504307D0 (en) Composition
GB201509044D0 (en) Composition
GB201505520D0 (en) Composition
GB201504665D0 (en) Composition
GB2538335B (en) Compositions
GB201506826D0 (en) Composition
HUE050837T2 (hu) Készítmények
GB201521384D0 (en) Composition
SG11201610547WA (en) Solid composition